ask="3.77"
ask_size="500"
average_daily_volume="44617"
bid="3.16"
bid_size="300"
book_value="-0.93"
change="-0.03"
change_from_200_day_moving_average="-0.38"
change_from_50_day_moving_average="-0.02"
change_from_52_week_high="-2.28"
change_From_52_week_low="1.41"
change_in_percent="-0.93%"
close="3.21"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.26"
ebitda="-50.77M"
eps_estimate_current_year="-2.06"
eps_estimate_next_quarter="-0.38"
eps_estimate_next_year="-1.48"
ex_dividend_date="N/A"
float_shares="10398000"
high="3.22"
high_52_weeks="5.49"
last_trade_date="3/14/2017"
last_trade_price="3.21"
last_trade_size="100"
last_trade_time="3:42pm"
low="3.05"
low_52_weeks="1.80"
market_capitalization="75.86M"
moving_average_200_day="3.59"
moving_average_50_day="3.23"
name="Oncobiologics
Inc."
notes="N/A"
one_year_target_price="9.67"
open="3.23"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-10.48%"
percent_change_from_50_day_moving_average="-0.64%"
percent_change_from_52_week_high="-41.53%"
percent_change_from_52_week_low="+77.95%"
previous_close="3.24"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="33.47"
revenue="2.29M"
shares_outstanding="23631000"
short_ratio="0.89"
stock_exchange="NGM"
symbol="ONS"
volume="15224"
weeks_range_52="1.80 - 5.49"
